⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
Pomerantz LLP Shares Class Action Details With Investors in ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
Investor Alert: Deadline Approaching to Join ARS Pharmaceuticals, Inc. (SPRY) Class Action – Contact Levi & Korsinsky
accessnewswire.com
SPRY
SPRY Shareholders Have Opportunity to Lead ARS Pharmaceuticals Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
accessnewswire.com
SPRY
Securities Fraud Class Action Filed Against ARS Pharmaceuticals, Inc. (SPRY) – Levi & Korsinsky Reminds Investors of October 5, 2026
accessnewswire.com
SPRY
Pomerantz LLP Shares Class Action Details With Investors in ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
SPRY UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
SPRY
Did You Lose Money on ARS Pharmaceuticals, Inc. (SPRY)? Levi & Korsinsky Urges Investors to Act Before October 5, 2026
accessnewswire.com
SPRY
Pomerantz LLP Reminds Shareholders: Securities Lawsuit Has Been Filed Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
ARS PHARMACEUTICALS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY
accessnewswire.com
SPRY
Pomerantz LLP Reminds Shareholders: Securities Lawsuit Has Been Filed Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY